Results 241 to 250 of about 215,816 (361)

Modified Sharp Recanalization for Inferior Vena Cava Occlusion in Patient with Budd-Chiari Syndrome. [PDF]

open access: yesInterv Radiol (Higashimatsuyama)
Koyama S   +7 more
europepmc   +1 more source

Chylothorax after patent ductus arteriosus ligation in a dog with persistent left cranial vena cava

open access: yesAustralian Veterinary Journal, EarlyView.
This report is the first to document chylothorax after patent ductus arteriosus (PDA) ligation in a dog with a persistent left cranial vena cava (PLCVC), highlighting potential complications arising from concurrent cardiovascular anomalies. A nine‐month‐old female desexed Pomeranian was referred for PDA. Echocardiography confirmed a left‐to‐right shunt
TR Nash, GL Hosgood
wiley   +1 more source

Superior Vena Cava–Right Pulmonary Artery Anastomosis

open access: bronze, 1969
Robert A. Achtel   +3 more
openalex   +1 more source

Effective and safe lead extraction using the bidirectional rotational Evolution\uae sheath in a child with congenital heart disease [PDF]

open access: yes, 2018
Cipriani, Alberto   +5 more
core   +1 more source

Factors in the development of liver transplantation [PDF]

open access: yes, 1985
Esquivel, CO   +7 more
core  

Astragaloside IV alleviates hypoxic pulmonary hypertension by inhibiting RELM‐β to reduce PINK1/Parkin‐mediated mitophagy in pulmonary artery smooth muscle cells (PASMCs)

open access: yesBritish Journal of Pharmacology, EarlyView.
Background and Purpose Hypoxic pulmonary hypertension (HPH) is a chronic disorder marked by irreversible pulmonary vascular remodelling (PVR) and pulmonary artery smooth muscle cell (PASMC) dysfunction. Astragaloside IV (AS‐IV), a natural saponin from Astragalus, shows potential in HPH management. This study explores AS‐IV's protective effect on PVR in
Rongzhen Ding   +12 more
wiley   +1 more source

A NEW METHOD OF BYPASSING THE OBSTRUCTED VENA CAVA

open access: bronze, 1961
R Schramel, Henry D.H. Olinde
openalex   +1 more source

Deep learning‐enhanced 3D imaging unveils semaglutide impact on cardiac fibrosis

open access: yesBritish Journal of Pharmacology, EarlyView.
Background and Purpose Myocardial fibrosis (MF), a hallmark of structural cardiac remodelling, drives disease progression across most forms of heart failure and plays a central role in heart failure with preserved ejection fraction (HFpEF). Despite its clinical relevance, effective treatments remain scarce.
Sheyla Barrado‐Ballestero   +11 more
wiley   +1 more source

Home - About - Disclaimer - Privacy